Drug Shortage Report for SINGULAIR
Report ID | 153981 |
Drug Identification Number | 02243602 |
Brand name | SINGULAIR |
Common or Proper name | montelukast tablets |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | MONTELUKAST |
Strength(s) | 4MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | R03DC |
ATC description | OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-02-18 |
Actual start date | 2022-02-03 |
Estimated end date | 2022-03-30 |
Actual end date | 2022-03-25 |
Shortage status | Resolved |
Updated date | 2022-03-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2022-03-28 | French | Compare |
v7 | 2022-03-28 | English | Compare |
v6 | 2022-03-11 | English | Compare |
v5 | 2022-02-04 | French | Compare |
v4 | 2022-02-04 | English | Compare |
v3 | 2022-02-01 | French | Compare |
v2 | 2022-02-01 | French | Compare |
v1 | 2022-02-01 | English | Compare |
Showing 1 to 8 of 8